These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 28497523

  • 1. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK, Saraf N, Saigal S, Choudhary NS, Goja S, Rastogi A, Bhangui P, Soin AS.
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [Abstract] [Full Text] [Related]

  • 2. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 3. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE, Perkins JD, Reyes JD, Montenovo MI.
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [Abstract] [Full Text] [Related]

  • 4. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS, Goja S, Yadav SK, Tamang TY, Rastogi A, Bhangui P, Thiagrajan S, Raut V, Babu RY, Saigal S, Saraf N, Choudhary NS, Vohara V.
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [Abstract] [Full Text] [Related]

  • 5. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [Abstract] [Full Text] [Related]

  • 6. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 7. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 8. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [Abstract] [Full Text] [Related]

  • 9. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.
    Transplantation; 2014 Feb 27; 97(4):457-62. PubMed ID: 24531822
    [Abstract] [Full Text] [Related]

  • 10. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 27; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 11. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS, Chen TH, Jeng LB, Yang HR, Li PC, Lee CC, Yeh CC, Lai HC, Su WP, Peng CY, Chen YF, Ho YJ, Tsai PP.
    Transplant Proc; 2012 Mar 27; 44(2):316-9. PubMed ID: 22410005
    [Abstract] [Full Text] [Related]

  • 12. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A, Patel MS, VanWagner LB, Lee WM, Asrani SK, Mufti AR, Rich NE, Vagefi PA, Shah JA, Kerr TA, Pedersen M, Hanish S, Singal AG, Cotter TG.
    Liver Transpl; 2024 Jan 01; 30(1):72-82. PubMed ID: 37490432
    [Abstract] [Full Text] [Related]

  • 13. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov 01; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 14.  Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.
    Li C, Wen TF, Yan LN, Li B, Yang JY, Xu MQ, Wang WT, Wei YG.
    Ann Hepatol; 2012 Nov 01; 11(4):471-7. PubMed ID: 22700628
    [Abstract] [Full Text] [Related]

  • 15. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
    Matoba D, Noda T, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, Tomimaru Y, Takahashi H, Doki Y, Eguchi H.
    Transplant Proc; 2023 May 01; 55(4):893-897. PubMed ID: 37120341
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 17. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH, Kim DG, Kang M, Koh HH, Choi MC, Min EK, Lee JG, Kim MS, Joo DJ.
    Int J Surg; 2023 Nov 01; 109(11):3459-3466. PubMed ID: 37565633
    [Abstract] [Full Text] [Related]

  • 18. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N, Itoh S, Nagatsu A, Soejima Y, Maehara Y.
    Liver Transpl; 2016 Dec 01; 22(12):1666-1675. PubMed ID: 27540888
    [Abstract] [Full Text] [Related]

  • 19. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
    Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, Hammad A, Okajima H, Uemoto S.
    Transplantation; 2016 Nov 01; 100(11):2416-2423. PubMed ID: 27495765
    [Abstract] [Full Text] [Related]

  • 20. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
    Dar FS, Bhatti AB, Dogar AW, Zia H, Amin S, Rana A, Nazer R, Khan NA, Khan EU, Rajput MZ, Salih M, Shah NH.
    Liver Transpl; 2015 Jul 01; 21(7):982-90. PubMed ID: 25891412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.